$UPXI 4 SEC Filings

Filed On	Filing
20 Jul 2026	Form 4: Salkind Gene, Director Received 100,000 shares as a grant or award
20 Jul 2026	Form 4: Dugan Lawrence, Director Received 100,000 shares as a grant or award
20 Jul 2026	Form 4: Rudick Brian Benjamin, Chief Strategy Officer Received 400,000 shares as a grant or award
20 Jul 2026	Form 4: Marshall Allan, Director Received 2,000,000 shares as a grant or award
20 Jul 2026	Form 4: Norstrud Andrew James, Director Received 400,000 shares as a grant or award
23 Dec 2025	Form 4: Marshall Allan, Director Bought 50,000 shares ($90K)
17 Dec 2025	Form 4: Marshall Allan, Director Received 1,600,000 shares as a grant or award · Bought 100,000 shares ($207K) · Bought 50,000 shares ($104K)
21 Nov 2025	Form 4: Salkind Gene, Director Bought 50,000 shares ($128K)
21 Nov 2025	Form 4: Norstrud Andrew James, Director Received 240,000 shares as a grant or award
18 Nov 2025	Form 4: Salkind Gene, Director Bought 200,000 shares ($546K)
30 Jul 2025	Form 4: Salkind Gene, Director Bought 20,243 shares ($100K) · Received 200,000 shares as a grant or award
24 Jul 2025	Form 4: Rudick Brian Benjamin, CSO Received 400,000 shares as a grant or award
24 Jul 2025	Form 4: Dugan Lawrence, Director Bought 1,000 shares ($5.17K) · Received 100,000 shares as a grant or award · Bought 11,000 shares ($62.6K) · 1 more
24 Jul 2025	Form 4: Williams Thomas Charles, Director Received 100,000 shares as a grant or award
24 Jul 2025	Form 4: Marshall Allan, Director Bought 161,943 shares ($800K) · Received 1,200,000 shares as a grant or award
24 Jul 2025	Form 4: Norstrud Andrew James, Director Received 250,000 shares as a grant or award
25 Apr 2025	Form 4: Williams Thomas Charles, Director Granted 25,000 Options to buy common stock
25 Apr 2025	Form 4: Marshall Allan, Director Acquired 125,000 Convertible Preferred Stock (Open Market Purchase) ($325K) · Bought 657,895 shares ($1.5M) · Received 75,000 shares as a grant or award · 1 more
25 Apr 2025	Form 4: Norstrud Andrew James, Director Bought 43,860 shares ($100K) · Received 100,000 shares as a grant or award
25 Apr 2025	Form 4: Salkind Gene, Director Granted 25,000 Options to buy common stock · Bought 241,229 shares ($550K) · Granted 35,000 Options to buy common stock

Comments